RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,170,658 | +111.7% | 806,622 | +106.7% | 0.00% | – |
| Q2 2023 | $2,915,011 | +68.5% | 390,229 | +50.5% | 0.00% | – |
| Q1 2023 | $1,729,978 | -32.7% | 259,367 | -22.2% | 0.00% | – |
| Q4 2022 | $2,568,748 | -12.5% | 333,171 | +20.7% | 0.00% | – |
| Q3 2022 | $2,937,000 | +62.7% | 275,942 | +24.5% | 0.00% | – |
| Q2 2022 | $1,805,000 | +79.2% | 221,704 | +57.7% | 0.00% | – |
| Q1 2022 | $1,007,000 | -49.1% | 140,597 | +21.7% | 0.00% | – |
| Q4 2021 | $1,978,000 | +787.0% | 115,501 | +1090.7% | 0.00% | – |
| Q3 2021 | $223,000 | +443.9% | 9,700 | +753.9% | 0.00% | – |
| Q2 2021 | $41,000 | – | 1,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
| Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
| Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
| MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
| MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
| ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
| Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |